GLP-2TZ is a synthetic dual GIP and GLP-1 receptor agonist peptide studied in preclinical and in-vitro research for its role in incretin signaling, glucose regulation, and metabolic pathways. Each vial is third-party tested for identity and purity (>99% HPLC verified). Supplied strictly for laboratory research use only — not for human or veterinary use, and not intended to diagnose, treat, cure, or prevent any disease.